CeriBell, Inc. (NASDAQ:CBLL) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 3, 2026, reporting third-quarter total revenue of $29.341 million and a continuing operating loss.

Key Highlights

  • Total revenue: $29.341 million for Q3 2026, up from $22.589 million in Q3 2025, according to the filing.
  • Nine-month revenue: $83.933 million for the nine months ended September 30, 2026, compared to $64.279 million for the same period in 2025.
  • Gross profit: $26.340 million for Q3 2026, versus $19.942 million in Q3 2025; nine-month gross profit was $75.400 million.
  • Total operating expenses: $46.888 million for Q3 2026, compared to $34.589 million in Q3 2025, with nine-month total operating expenses of $136.674 million.
  • Total assets: $156.370 million as of September 30, 2026, down from $195.803 million as of December 31, 2025.
  • Accumulated deficit: $280.712 million as of September 30, 2026, compared to $220.356 million as of December 31, 2025.
  • Shares outstanding: 38,835,010 shares of common stock as of October 30, 2026, per the filing.

CeriBell Reports Q3 2026 Revenue Growth Alongside Widening Operating Loss

According to the filing, CeriBell, Inc. generated total revenue of $29.341 million for the three months ended September 30, 2026, consisting of product revenue of $22.235 million and subscription revenue of $7.106 million. This compares to total revenue of $22.589 million in the same quarter of 2025, which included product revenue of $17.020 million and subscription revenue of $5.569 million. For the nine months ended September 30, 2026, the company reported total revenue of $83.933 million versus $64.279 million in the prior-year period.

The filing disclosed total cost of revenue of $3.001 million for Q3 2026, yielding a gross profit of $26.340 million. Total operating expenses for the quarter were $46.888 million, broken down as research and development of $7.403 million, sales and marketing of $25.032 million, and general and administrative expenses of $14.453 million. For the nine-month period, total operating expenses reached $136.674 million, compared to $100.437 million for the nine months ended September 30, 2025.

As of September 30, 2026, the company reported total assets of $156.370 million, including cash and cash equivalents of $41.989 million and marketable securities of $75.478 million. Total liabilities stood at $38.833 million, including notes payable, long-term, of $20.000 million. Total stockholders' equity was $117.537 million, with an accumulated deficit of $280.712 million. The company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company in the filing.

What Was Disclosed

CeriBell filed its quarterly report covering financial results for the three and nine months ended September 30, 2026. The filing includes condensed balance sheets, statements of operations, stockholders' equity, and cash flows, along with management's discussion and risk factors.